Plastic Surgery Practice
  • Client Objectives
    • Aesthetics
    • Dermatology
    • Rejuvenation
  • Practice Management
    • Marketing
    • Office Management
    • Technology
  • Treatment Solutions
    • Innovations
    • Products
    • Pharmaceuticals
  • Resources
    • Podcasts
    • Videos
    • Webinars
    • White Papers

Select Page

Tag: Apyx Medical Corporation

All

Popular
Renuvion Safely and Effectively Treats Lax Skin in Trial

Renuvion Safely and Effectively Treats Lax Skin in Trial

In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.

  • Apyx Medical Submits FDA 510(k) to Add Power Liposuction to Body Contouring System

  • Apyx Medical Corp Receives Regulatory Clearance to Market and Sell Its Helium Plasma Technology Products in Five New Countries

  • Apyx Medical Corporation Announces Two Peer-Reviewed Clinical Publications Evaluating Renuvion’s Helium Plasma Technology

  • Apyx Receives FDA Approval to Begin Phase II of US IDE Study

  • Renuvion Maker Submits 510(k) Request for APR Handpiece

  • FDA OKs Renuvion Dermal-Resurfacing Technology

  • FDA Clears Renuvion Dermal Headpiece for Wrinkle-Reduction Procedures 

  • FDA Clears Renuvion for Neck Laxity Procedures

All

Latest
FDA Clears All-in-One Body Contouring System

FDA Clears All-in-One Body Contouring System

The platform integrates fat removal, closed-loop contouring, tissue contraction, and electrosurgical capabilities.

  • Plastic Surgeons Back Renuvion in Testimonial Video

    Plastic Surgeons Back Renuvion in Testimonial Video

All

Latest
What’s Fueling—and Slowing—the Global Surge in HA Fillers?

What’s Fueling—and Slowing—the Global Surge in HA Fillers?

A new report reveals shifting forces behind the rising use of hyaluronic acid fillers worldwide.

  • FDA Clears Expanded Indications for Swift Microwave Wart Device

    FDA Clears Expanded Indications for Swift Microwave Wart Device

  • Regenerative and Personalized Care Lead 2026 Facial Plastic Surgery Trends

    Regenerative and Personalized Care Lead 2026 Facial Plastic Surgery Trends

  • Allergan Aesthetics to Present Phase 3 Data for First-in-Class Botulinum Neurotoxin E

    Allergan Aesthetics to Present Phase 3 Data for First-in-Class Botulinum Neurotoxin E

Sorry, No Posts Found

Plastic Surgery Practice

7300 W 110th St – Floor 7
Overland Park, KS 66210
(913) 955-2600

Our Parent Company

MEDQOR LLC

About MEDQOR

MEDQOR Data Platform

Press Releases

Key Resources

Podcasts

Webinars

White Papers

Videos

Helpful Links

Media Solutions Kit

Subscribe Now

Contact Us

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Copyright

Privacy Policy

Terms of Service

© 2024 MEDQOR LLC. All Rights Reserved